Nature of Query:
The National Stock Exchange of India Ltd. sought clarification from Banka BioLoo Limited regarding significant movement in the price of the company's securities in the recent past. The query was raised via NSE Letter No. NSE/CM/Surveillance/17776 dated 9 November 2026.
Company Response / Clarification:
The company stated that it has made all necessary disclosures in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Management confirmed that as of 10 November 2026, there are no pending announcements that would have a bearing on the price movement of the scrip. The company explicitly denied sharing any price sensitive information with any market intermediary or other party. The response attributed the price spurt purely to market conditions and stated it was "absolutely market driven," with the company having no connection to the price movement.
Regulatory Reference / Compliance:
The company explicitly referenced compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The response affirmed that the company has made and will continue to make all requisite disclosures and intimations to the Exchange in compliance with SEBI LODR regulations and other applicable listing regulations.
Analyst Perspective / Material Implications:
No material operational or strategic insights were disclosed in the clarification. The company's response indicates no fundamental company-specific developments driving the price movement, suggesting the volatility was likely due to broader market sentiment or trading activity rather than underlying business changes.